**Core Concept**
Thiazolidinediones are a class of medications used in the treatment of type 2 diabetes mellitus. They work by activating peroxisome proliferator-activated receptor gamma (PPARγ), which regulates glucose and lipid metabolism. This activation leads to increased insulin sensitivity and glucose uptake in the muscles.

**Why the Correct Answer is Right**
The correct answer is related to the side effect profile of thiazolidinediones. Activation of PPARγ also affects the cardiovascular system, leading to increased permeability of blood vessels and decreased vascular tone. This can result in fluid retention and increased risk of heart failure. Additionally, the activation of PPARγ can also lead to an increase in the levels of triglycerides and LDL cholesterol, further exacerbating cardiovascular risk.

**Why Each Wrong Option is Incorrect**
**Option A:**
This option is incorrect because while thiazolidinediones can cause weight gain, it is not the most significant risk associated with their use.

**Option B:**
This option is incorrect because thiazolidinediones are not typically associated with an increased risk of pancreatitis.

**Option C:**
This option is incorrect because while thiazolidinediones can cause hypoglycemia when used in combination with other diabetes medications, it is not the most significant risk associated with their use.

**Clinical Pearl / High-Yield Fact**
It is essential to note that thiazolidinediones should be used with caution in patients with a history of heart failure or those with risk factors for cardiovascular disease. Regular monitoring of renal function, liver enzymes, and lipid profiles is also crucial when prescribing these medications.

**Correct Answer:** C. Heart failure.